Back
Capricor Therapeutics Stock Price Chart
Buy
73
CAPR
Capricor Therapeutics
Last Price:
6.22
Seasonality Move:
8.34%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CAPR is experiencing slight buying pressure.
Capricor Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.49 | Buy |
| 20-day SMA: | 5.34 | Buy |
| 50-day SMA: | 5.93 | Buy |
| 200-day SMA: | 4.78 | Buy |
| 8-day EMA: | 5.58 | Buy |
| 20-day EMA: | 5.52 | Buy |
| 50-day EMA: | 5.5 | Buy |
| 200-day EMA: | 4.9 | Buy |
Capricor Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 63.72 | Buy |
| Chaikin Money Flow: | 77582 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.06 - 5.68) | Buy |
| Bollinger Bands (100): | (4.17 - 6.13) | Buy |
Capricor Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Capricor Therapeutics Stock
Is Capricor Therapeutics Stock a Buy?
- Capricor Therapeutics share price is 6.20 while CAPR 8-day simple moving average is 5.49, which is a Buy signal.
- The stock price of CAPR is 6.20 while Capricor Therapeutics 20-day SMA is 5.34, which makes it a Buy.
- Capricor Therapeutics 50-day simple moving average is 5.93 while CAPR share price is 6.20, making it a Buy technically.
- CAPR stock price is 6.20 and Capricor Therapeutics 200-day simple moving average is 4.78, creating a Buy signal.
CAPR Technical Analysis vs Fundamental Analysis
Buy
73
Capricor Therapeutics (CAPR)
is a Buy
Is Capricor Therapeutics a Buy or a Sell?
-
Capricor Therapeutics stock is rated a Buy
The current Capricor Therapeutics [CAPR] share price is $6.20. The Score for CAPR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Capricor Therapeutics Stock Info
Market Cap:
197.23M
Price in USD:
6.20
Share Volume:
755.11K
Capricor Therapeutics 52-Week Range
52-Week High:
8.22
52-Week Low:
2.68
Buy
73
Capricor Therapeutics (CAPR)
is a Buy
Capricor Therapeutics Share Price Forecast
-
What is the Capricor Therapeutics stock price today?
The Capricor Therapeutics stock price is 6.20 USD today. -
Will CAPR stock go up or go down?
Capricor Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Capricor Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Capricor Therapeutics is not overvalued.
Is Capricor Therapeutics Stock a Buy?
- Capricor Therapeutics share price is 6.20 while CAPR 8-day exponential moving average is 5.58, which is a Buy signal.
- The stock price of CAPR is 6.20 while Capricor Therapeutics 20-day EMA is 5.52, which makes it a Buy.
- Capricor Therapeutics 50-day exponential moving average is 5.50 while CAPR share price is 6.20, making it a Buy technically.
- CAPR stock price is 6.20 and Capricor Therapeutics 200-day simple moving average is 4.90, creating a Buy signal.
Fundamental Analysis of Capricor Therapeutics
Is Capricor Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.16 per share, and an increase next year of $0.74 per share.
Technical Analysis of Capricor Therapeutics
Should I short Capricor Therapeutics stock?
- CAPR Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Capricor Therapeutics is a Sell
- Capricor Therapeutics Relative Strength Index (RSI) is 63.72, which suggest Capricor Therapeutics is overbought
- The Bollinger Bands (25) for Capricor Therapeutics is (5.06 - 5.68), which suggest Capricor Therapeutics is a Buy
- The Bollinger Bands (100) for Capricor Therapeutics is (4.17 - 6.13), which suggest Capricor Therapeutics is a Buy
* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.